Gain Therapeutics downgraded to neutral from buy at B. Riley

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Gain Therapeutics Inc.

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never before targeted. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply